^
BIOMARKER:

FGFR3 overexpression

i
Other names: FGFR3, ACH, CD333, CEK2, JTK4, Fibroblast growth factor receptor 3
Entrez ID:
FGFR3 overexpression
Urothelial Cancer
atezolizumab + BAY1163877
Sensitive: C2 – Inclusion Criteria
FGFR3 overexpression
Head and Neck Cancer
BAY1163877
Sensitive: C3 – Early Trials
FGFR3 overexpression
Lung Non-Small Cell Squamous Cancer
BAY1163877
Resistant: C3 – Early Trials
FGFR3 overexpression
Bladder Cancer
TAS 120
Sensitive: D – Preclinical
FGFR3 overexpression
SCCHN
BAY1163877
Sensitive: D – Preclinical
FGFR3 overexpression
SCCHN
infigratinib
Sensitive: D – Preclinical
FGFR3 overexpression
Breast Cancer
FGFR inhibitor
Sensitive: D – Preclinical